Cannabinoid CB1 receptor modulators

摘要

Provided is a compound of formula (I), or a salt, hydrate, solvate, single enantiomer or N-oxide thereof. The compound can be used to treat various diseases or conditions directly or indirectly associated with obesity and overweight selected from metabolic syndrome, type 2 diabetes, cardiovascular disease, metabolic dysfunction, metabolic disease or disorder, or liver disease; or for the treatment of an eating disorder, an addictive disorder, a mental disorder, a neurological disorders, sexual dysfunction, reproductive dysfunction, liver disease or fibrosis-related disease.